Finding the Right Place for Dual HER2 Blockade in Breast Cancer and Beyond
Source: OncLive Although drugs that target HER2 have transformed the prognosis for many patients...
WHAT'S UP IN
Trastuzumab
Pegram Excited for Additional Advances in HER2+ Breast Cancer
Mark Pegram, MD Though some clinicians may characterize the treatment landscape of HER2-positive...
The Last Mile
Before sunrise on February 22, 2013, Alexander Hardy, a Genentech vice president at the time, was...
A Pilot Study of a Brief Pre-Operative Intervention for Patients Undergoing Breast Surgery
Summary This study is to assess the feasibility of using a positive activities intervention,...
